Valentina Frezza

Valentina Frezza

Auto-generated profile, based on publicly available information

Valentina Frezza

Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
EMElisa Maria Memmi
Elisa Maria Memmi
ASAnna Giulia Sanarico
Anna Giulia Sanarico
AGArianna Giacobbe
Arianna Giacobbe
APAngelo Peschiaroli
Angelo Peschiaroli
VFValentina Frezza
Valentina Frezza
FBFrancesca Bernassola
Francesca Bernassola
The predominant p63 isoform, ΔNp63, is a master regulator of normal epithelial stem cell (SC) maintenance. However, in vivo evidence of the regulation of cancer stem cell (CSC) properties by p63 is still limited. Here, we exploit the transgenic MMTV-ErbB2 (v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2) mouse model of carcinogenesis to dissect the role of p63 in the regulation of mammary CSC self-renewal and breast tumorigenesis. ErbB2 tumor cells enriched for SC-like properties display increased levels of ΔNp63 expression compared with normal mammary progenitors. Down-regulation of p63 in ErbB2 mammospheres markedly restricts self-renewal and expansion of CSCs, and this action is fully independent of p53. Furthermore, transplantation of ErbB2 progenitors expressing shRNAs against p63 into the mammary fat pads of syngeneic mice delays tumor growth in vivo. p63 knockdown in ErbB2 progenitors diminishes the expression of genes encoding components of the Sonic Hedgehog (Hh) signaling pathway, a driver of mammary SC self-renewal. Remarkably, p63 regulates the expression of Sonic Hedgehog (Shh), GLI family zinc finger 2 (Gli2), and Patched1 (Ptch1) genes by directly binding to their gene regulatory regions, and eventually contributes to pathway activation. Collectively, these studies highlight the importance of p63 in maintaining the self-renewal potential of mammary CSCs via a positive modulation of the Hh signaling pathway.

17 March 2020 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
LCLIDIA CHELLINI
LIDIA CHELLINI
VFValentina Frezza
Valentina Frezza
MPMaria Paola Paronetto
Maria Paola Paronetto
In-depth analysis of global RNA sequencing has enabled a comprehensive overview of cellular transcriptomes and revealed the pervasive transcription of divergent RNAs from promoter regions across eukaryotic genomes. These studies disclosed that genomes encode a vast repertoire of RNAs beyond the well-known protein-coding messenger RNAs. Furthermore, they have provided novel insights into the regulation of eukaryotic epigenomes, and transcriptomes, including the identification of novel classes of noncoding transcripts, such as the promoter-associated noncoding RNAs (pancRNAs).PancRNAs are defined as transcripts transcribed within few hundred bases from the transcription start sites (TSSs) of protein-coding or non-coding genes. Unlike the long trans-acting ncRNAs that regulate expression of target genes located in different chromosomal domains and displaying their function both in the nucleus and in the cytoplasm, the pancRNAs operate as cis-acting elements in the transcriptional regulation of neighboring genes. PancRNAs are very recently emerging as key players in the epigenetic regulation of gene expression programs in development and diseases.Herein, we review the complex epigenetic network driven by pancRNAs in eukaryotic cells, their impact on physiological and pathological states, which render them promising targets for novel therapeutic strategies.

1 July 2017 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
VFValentina Frezza
Valentina Frezza
Alessandro TerrinoniAlessandro Terrinoni
Alessandro Terrinoni
CPConsuelo Pitolli
Consuelo Pitolli
AMAlessandro Mauriello
Alessandro Mauriello
GMGerry Melino
Gerry Melino
ECEleonora Candi
Eleonora Candi

28 December 2018 in Aging
Verified
Journal Article
Open access
VFValentina Frezza
Valentina Frezza
CFClaudia Fierro
Claudia Fierro
EGElena Gatti
Elena Gatti
APAngelo Peschiaroli
Angelo Peschiaroli
ALAnna Maria Lena
Anna Maria Lena
FBFrancesca Bernassola
Francesca Bernassola
Accumulating evidence has proved that deregulation of Delta Np63 expression plays an oncogenic role in head and neck squamous cell carcinomas (HNSCCs). Besides p63, the type 1-insulin-like growth factor (IGF) signalling pathway has been implicated in HNSCC development and progression. Most insulin/IGF1 signalling converges intracellularly onto the protein adaptor insulin receptor substrate-1 (IRS-1) that transmits signals from the receptor to downstream effectors, including the PI3K/AKT and the MAPK kinase pathways, which, ultimately, promote proliferation, invasion, and cell survival. Here we report that p63 directly controls IRS1 transcription and cellular abundance and fosters the PI3K/AKT and MAPK downstream signalling pathways. Inactivation of Delta Np63 expression indeed reduces tumour cell responsiveness to IGF1 stimulation, and inhibits the growth potential of HNSCC cells. In addition, a positive correlation was observed between p63 and IRS1 expression in human HNSCC tissue arrays and in publicly available gene expression data. Our findings indicate that aberrant expression of Delta Np63 in HNSSC may act as an oncogenic stimulus by altering the IGF signalling pathway.

8 July 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
CFClaudia Fierro
Claudia Fierro
SGSara Giovannini
Sara Giovannini
VMValeria Moriconi
Valeria Moriconi
CFClaudia Fiorilli
Claudia Fiorilli
EPEmanuele Panatta
Emanuele Panatta
FBFrancesca Bernassola
Francesca Bernassola
To uncover substrates mediating the oncogenic activity of WWP1 in acute myeloid leukemia (AML), we performed a proteomic analysis that identified the histone demethylase KDM5B /JARID1B as a candidate target. Of note, JARID1B is indispensable for efficient recruitment of several DNA damage repair factors and for damage resolution, thus negatively influencing the sensitivity of cancer cells to chemo- and radiation therapies. Validation of JARID1B as a substrate of WWP1 revealed a positive regulation of JARID1B half-life by WWP1 through the establishment of K63-linked polyubiquitin chains. As a result, downregulation of JARID1B rising from WWP1 inactivation was associated with higher H3K4me3 enrichment at JARID1B target genes in WWP1-depleted relatively to control AML cells. Integration of RNA-seq and H3K4me3 ChIP-seq data uncovered a highly significant overlap between upregulated gene expression and enriched H3K4me3 peaks after shWWP1 inactivation. We confirmed transcriptional activation of JARID1B targets in WWP1-depleted cells, supporting a role for WWP1 in regulating JARID1B activity. Coherently, upon WWP1 inactivation, we observed a defective recruitment of repair proteins after DNA damage, with subsequent reduced DNA damage repair efficiency and enhanced sensitization of AML cells to the cytotoxic activity of chemotherapeutic drugs. All together, these data identify JARID1B as a bona fide target of WWP1 and imply that WWP1-mediated regulation of JARID1B impacts its ability to modify chromatin and to recruit DNA damage repair factors, thus ultimately affecting chemosensitivity of AML cells.

25 February 2026 in Cell Death & Differentiation
Verified
Journal Article
Open access
YSYufang Shi
Yufang Shi
VFValentina Frezza
Valentina Frezza
CMCarlos Sanchez Martin
Carlos Sanchez Martin
WCWen-Lian Chen
Wen-Lian Chen
WJWei Jia
Wei Jia
GMGerry Melino
Gerry Melino